Clinical Trial Update: Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

View source ↗

Summary

A completed clinical trial comparing error rates between the ELLIPTA dry powder inhaler and other dry powder inhalers in patients with chronic obstructive pulmo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ELLIPTA

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2019-06-10